HIV-1 integrase resistance among antiretroviral treatment naive and experienced patients from Northwestern Poland

HIV-1 integrase resistance among antiretroviral treatment naive and experienced patients from Northwestern Poland

<p>Abstract</p> <p>Background</p> <p>HIV integrase inhibitor use is limited by low genetic barrier to resistance and possible cross-resistance among representatives of this class of antiretrovirals. The aim of this study was to analyse integrase sequence variability amo...

Full description

Bibliographic Details
Main Authors: Parczewski Miłosz, Bander Dorota, Urbańska Anna, Boroń-Kaczmarska Anna
Format: Article
Language:English
Published: BMC 2012-12-01
Series:BMC Infectious Diseases
Subjects:
HIV-1
Integrase inhibitors
Raltegravir
Antiretroviral treatment failure
Drug resistance mutations
Online Access:http://www.biomedcentral.com/1471-2334/12/368

Internet

http://www.biomedcentral.com/1471-2334/12/368

Similar Items